Pharmaresearch Product Rises 2.81% Amid Botox (Botulinum Toxin) Theme Uptrend
On the 24th, the Botox (Botulinum toxin) theme showed strength by rising 3.57% compared to the previous day, while PharmaResearch Product, which is gaining attention as a related stock, surged 2.81% compared to the previous day. PharmaResearch Product is known as a regenerative bio pharmaceutical company.
[Graph] Major stock price changes in the Botox (Botulinum toxin) theme
According to the analysis by Thinkpool Robo Algorithm RASSI, PharmaResearch Product ranked 3rd out of 10 stocks in the quant financial ranking by exceeding the theme’s average scores in growth, stability, and profitability. This can be interpreted as PharmaResearch Product having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.
[Table] Top stocks by financial scores within the theme
※ The quant financial scores are results analyzed by the robo algorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.